Sra-333
Ensure the Legality and Compliance of the Testing Process
Changchun University of Chinese MedicineEarly Phase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Ensure the Legality and Compliance of the Testing Process cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Jiedu Yizhi Formula Changchun University of Chinese Medicine | Early Phase 1 | CC |
Same molecule, other indications
Sra-333 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →